David A. Downs

1.0k total citations
33 papers, 767 citations indexed

About

David A. Downs is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, David A. Downs has authored 33 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in David A. Downs's work include Neurotransmitter Receptor Influence on Behavior (15 papers), Neuropeptides and Animal Physiology (6 papers) and Receptor Mechanisms and Signaling (5 papers). David A. Downs is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (15 papers), Neuropeptides and Animal Physiology (6 papers) and Receptor Mechanisms and Signaling (5 papers). David A. Downs collaborates with scholars based in United States. David A. Downs's co-authors include James N. Wiley, James H. Woods, James H. Woods, Thomas G. Heffner, J H Woods, Linda L. Coughenour, Robert F. Bruns, Ann E. Williams, Seymore Herling and John M. Carney and has published in prestigious journals such as Pharmacological Reviews, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

David A. Downs

33 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Downs United States 18 502 333 101 95 92 33 767
J�rgen Engel Sweden 17 636 1.3× 344 1.0× 30 0.3× 103 1.1× 122 1.3× 25 892
Kathy M. O’Boyle Ireland 21 1.0k 2.1× 719 2.2× 11 0.1× 84 0.9× 94 1.0× 36 1.4k
R. James Collins United States 14 746 1.5× 463 1.4× 37 0.4× 176 1.9× 111 1.2× 18 963
C.A. Korduba United States 8 690 1.4× 523 1.6× 8 0.1× 85 0.9× 67 0.7× 24 975
Gerald T. Pollard United States 19 618 1.2× 341 1.0× 66 0.7× 58 0.6× 131 1.4× 42 931
Richard E. Chipkin United States 21 856 1.7× 559 1.7× 9 0.1× 328 3.5× 173 1.9× 52 1.3k
A. Barbara Pflueger United States 15 424 0.8× 217 0.7× 17 0.2× 71 0.7× 51 0.6× 18 637
Arnold B. Davidson United States 11 196 0.4× 130 0.4× 44 0.4× 31 0.3× 114 1.2× 16 561
G. A. Deneau United States 9 596 1.2× 244 0.7× 108 1.1× 99 1.0× 128 1.4× 10 865
J. Gerald Young United States 19 228 0.5× 160 0.5× 60 0.6× 49 0.5× 303 3.3× 28 937

Countries citing papers authored by David A. Downs

Since Specialization
Citations

This map shows the geographic impact of David A. Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Downs more than expected).

Fields of papers citing papers by David A. Downs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Downs. The network helps show where David A. Downs may publish in the future.

Co-authorship network of co-authors of David A. Downs

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Downs. A scholar is included among the top collaborators of David A. Downs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Downs. David A. Downs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Downs, David A., et al.. (1996). Effects of a Glucose Polymer Sports Drink on Blood Glucose, Insulin, and Performance in Subjects With Diabetes. The Diabetes Educator. 22(5). 471–480. 12 indexed citations
2.
Downs, David A., et al.. (1992). Pharmacologic activity of CI-977, a selective kappa opioid agonist, in rhesus monkeys.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 1044–1049. 18 indexed citations
3.
Heffner, Thomas G., James N. Wiley, Ann E. Williams, et al.. (1989). Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology. 98(1). 31–37. 90 indexed citations
4.
Hershenson, Fred M., Lawrence D. Wise, David A. Downs, et al.. (1988). Synthesis and potential antipsychotic activity of 1H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidines. Journal of Medicinal Chemistry. 31(2). 454–461. 17 indexed citations
5.
Davis, Robert E., Michael J. Callahan, & David A. Downs. (1988). Clonidine disrupts aged‐monkey delayed response performance. Drug Development Research. 12(3-4). 279–286. 18 indexed citations
6.
Bridges, Alexander J., Walter H. Moos, Bharat K. Trivedi, et al.. (1987). N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. Journal of Medicinal Chemistry. 30(10). 1709–1711. 39 indexed citations
7.
Wise, Lawrence D., Donald E. Butler, Linda L. Coughenour, et al.. (1987). 1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agents. Journal of Medicinal Chemistry. 30(10). 1807–1812. 29 indexed citations
8.
Wise, Lawrence D., Donald E. Butler, Linda L. Coughenour, et al.. (1986). (5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones. A series of novel potential antipsychotic agents. Journal of Medicinal Chemistry. 29(9). 1628–1637. 3 indexed citations
9.
Deupree, Jean D., Joël M. Weaver, & David A. Downs. (1982). Catecholamine content of chromaffin granule ‘ghosts’ isolated from bovine adrenal glands. Biochimica et Biophysica Acta (BBA) - General Subjects. 714(3). 471–478. 8 indexed citations
10.
Downs, David A., et al.. (1981). Pharmacological evaluation of narcotic antagonist delivery systems in rhesus monkeys.. PubMed. 28. 77–92. 17 indexed citations
11.
Wiley, James N. & David A. Downs. (1979). Naloxone-precipitated jumping in mice pretreated with acute injections of opioids. Life Sciences. 25(9). 797–801. 97 indexed citations
12.
Herling, Seymore, David A. Downs, & James H. Woods. (1979). Cocaine, d-amphetamine, and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys. Psychopharmacology. 64(3). 261–269. 34 indexed citations
13.
Downs, David A., et al.. (1978). Continuous intravenous naltrexone effects on morphine self-administration in rhesus monkeys.. Journal of Pharmacology and Experimental Therapeutics. 204(2). 481–486. 31 indexed citations
14.
Downs, David A. & J H Woods. (1976). Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons.. Journal of Pharmacology and Experimental Therapeutics. 196(2). 298–306. 50 indexed citations
15.
Herling, Seymore, David A. Downs, & J H Woods. (1975). Rate dependent effects of drugs on food and cocaine reinforced lever press responding in rhesus monkeys. Federation Proceedings. 34(3). 2 indexed citations
16.
Downs, David A. & James H. Woods. (1975). Naloxone as a Negative Reinforcer in Rhesus Monkeys: Effects of Dose, Schedule, and Narcotic Regimen. Pharmacological Reviews. 27(3). 397–406. 31 indexed citations
17.
Downs, David A. & James H. Woods. (1975). FIXED‐RATIO ESCAPE AND AVOIDANCE‐ESCAPE FROM NALOXONE IN MORPHINE‐DEPENDENT MONKEYS: EFFECTS OF NALOXONE DOSE AND MORPHINE PRETREATMENT1. Journal of the Experimental Analysis of Behavior. 23(3). 415–427. 17 indexed citations
18.
Downs, David A. & J H Woods. (1974). Effects of morphine, pentazocine, and naloxone on operant responding in monkeys and pigeons. 16(2). 1 indexed citations
19.
Downs, David A. & James H. Woods. (1974). CODEINE- AND COCAINE-REINFORCED RESPONDING IN RHESUS MONKEYS: EFFECTS OF DOSE ON RESPONSE RATES UNDER A FIXED-RATIO SCHEDULE. Journal of Pharmacology and Experimental Therapeutics. 191(1). 179–188. 52 indexed citations
20.
Carney, John M., James H. Woods, & David A. Downs. (1973). Dose dependent production and measurement of morphine tolerance and cross tolerance. 15(2). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026